- Home
- WVE vs NAC Comparison
WVE vs NAC Comparison
Compare WVE & NAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVE
- NAC
- Stock Information
- Founded
- WVE 2012
- NAC 1998
- Country
- WVE Singapore
- NAC France
- Employees
- WVE N/A
- NAC N/A
- Industry
- WVE Biotechnology: Pharmaceutical Preparations
- NAC Investment Managers
- Sector
- WVE Health Care
- NAC Finance
- Exchange
- WVE Nasdaq
- NAC Nasdaq
- Market Cap
- WVE 1.8B
- NAC 1.7B
- IPO Year
- WVE 2015
- NAC N/A
- Fundamental
- Price
- WVE $11.13
- NAC $11.45
- Analyst Decision
- WVE Strong Buy
- NAC
- Analyst Count
- WVE 10
- NAC 0
- Target Price
- WVE $21.60
- NAC N/A
- AVG Volume (30 Days)
- WVE 734.1K
- NAC 307.3K
- Earning Date
- WVE 03-05-2025
- NAC 01-01-0001
- Dividend Yield
- WVE N/A
- NAC 4.33%
- EPS Growth
- WVE N/A
- NAC N/A
- EPS
- WVE N/A
- NAC N/A
- Revenue
- WVE $53,610,000.00
- NAC N/A
- Revenue This Year
- WVE N/A
- NAC N/A
- Revenue Next Year
- WVE $48.58
- NAC N/A
- P/E Ratio
- WVE N/A
- NAC N/A
- Revenue Growth
- WVE N/A
- NAC N/A
- 52 Week Low
- WVE $4.01
- NAC $9.32
- 52 Week High
- WVE $16.74
- NAC $11.21
- Technical
- Relative Strength Index (RSI)
- WVE 44.53
- NAC 55.91
- Support Level
- WVE $10.79
- NAC $11.40
- Resistance Level
- WVE $11.78
- NAC $11.52
- Average True Range (ATR)
- WVE 0.69
- NAC 0.07
- MACD
- WVE 0.05
- NAC 0.00
- Stochastic Oscillator
- WVE 43.95
- NAC 60.53
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
About NAC Nuveen California Quality Municipal Income Fund
Nuveen California Quality Municipal Income Fund is a diversified closed-end management investment company. Its objective is to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal and California state income taxes. It invests a majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.